All of the following are true about Triptans except:
**Core Concept**
Triptans are a class of selective 5-HT1B/1D receptor agonists used in the acute treatment of migraine attacks. They work by causing vasoconstriction of the intracranial blood vessels and inhibiting the release of pro-inflammatory neuropeptides.
**Why the Correct Answer is Right**
Triptans are effective in treating migraines because they bind to 5-HT1B and 1D receptors on the blood vessels and nerve endings in the brain. This binding causes the blood vessels to constrict, which helps to alleviate the pain and other symptoms associated with migraines. Additionally, triptans inhibit the release of calcitonin gene-related peptide (CGRP), a neuropeptide that plays a key role in the pathophysiology of migraines.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because triptans do not have a significant effect on the release of serotonin from platelets.
**Option B:** Incorrect because triptans are not effective in treating cluster headaches, which have a different pathophysiology than migraines.
**Option C:** Incorrect because while triptans can cause vasoconstriction, they do not have a significant effect on the cardiovascular system.
**Clinical Pearl / High-Yield Fact**
Triptans should not be used in patients with cardiovascular disease, as they can cause vasoconstriction and potentially worsen cardiac conditions.
**Correct Answer: B. Triptans are not effective in treating cluster headaches.**